Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

SHBG may be a useful early indicator and treatment target for PCOS.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Muscles can make their own androgens, which may help muscle growth.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.